SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

AAREY DRUGS & PHARMACEUTICALS

BSE: 524412 28 Jun 2025
Healthcare
₹ 59.45
Aarey Drugs & Pharmaceuticals Ltd specializes in Pharmaceuticals within the Healthcare sector.

AAREY DRUGS & PHARMACEUTICALS - Share Price & Details

Market Cap
₹161.0
High /Low
75.8 / 31.3
Stock P/E
40.2
Book Value
₹48.8
Dividend Yield
0.0
ROCE
6.0
ROE
₹2.96
Face Value
10.0
PEG Ratio
-5.71
EVEBITDA
₹16.1
Debt
34.9
CMP / FCF
-307.0
Debt to equity
₹0.25
NP Ann
4.02
High price all time
144.0
Piotroski score
₹4.0
Graham Number
39.5
No. Eq. Shares
2.84
Net CF
₹-0.12
Net profit
4.02
Price to book value
1.17
Interest Coverage
₹2.52
Low price all time
9.02
Industry PE
32.0
Reserves
₹110
Free Cash Flow
₹4.45

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
AAREY DRUGS & PHARMACEUTICALSNANANANA161.040.2
AURO LABORATORIES LTD.NANANANA15986.3
BAL PHARMA LTD.NANANANA15821.9

Peer Comparison Chart


About AAREY DRUGS & PHARMACEUTICALS

Aarey Drugs & Pharmaceuticals Ltd, with Security Code 524412, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Aarey Drugs & Pharmaceuticals Faces Mixed Technical Signals Amid Declining Sales and Losses

(17 Jun 2025)
Aarey Drugs & Pharmaceuticals has experienced a recent evaluation adjustment, reflecting mixed technical indicators.
Read more →

How has been the historical performance of the Aarey Drugs?

(11 Jun 2025)
Aarey Drugs has experienced fluctuating financial performance, with net sales peaking at Rs 492.68 crore in March 2022, declining to Rs...
Read more →

Aarey Drugs & Pharmaceuticals Faces Mixed Signals Amid Financial Challenges and Technical Shift

(10 Jun 2025)
Aarey Drugs & Pharmaceuticals has experienced a recent evaluation adjustment, indicating a shift in technical trends.
Read more →

Has Aarey Drugs declared dividend?

(07 Jun 2025)
Aarey Drugs & Pharmaceuticals Ltd has declared a 1% dividend, amounting to ₹0.10 per share, with an ex-date of December 13, 2018.
Read more →

Aarey Drugs & Pharmaceuticals Sees Significant Buying Activity Amid Price Rebound

(05 Jun 2025)
Aarey Drugs & Pharmaceuticals Ltd is experiencing notable buying activity, with the stock rebounding after three days of decline.
Read more →

Aarey Drugs Reports Declining Sales and Profitability Challenges in March 2025 Results

(31 May 2025)
Aarey Drugs & Pharmaceuticals has reported its financial results for the quarter ending March 2025, highlighting operational challenges.
Read more →